Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison.
Journal: BMJ oncology
Published: June 16, 2025
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.
Journal: EClinicalMedicine
Published: October 17, 2022
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 15, 2020
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 28, 2019
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.
Journal: British journal of cancer
Published: December 27, 2018
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity.
Journal: BMJ case reports
Published: April 13, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
Journal: The oncologist
Published: March 14, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
Journal: Pediatric blood & cancer
Published: November 14, 2017
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 31, 2017
Evaluation of Quality of Life at Progression in Patients with Soft Tissue Sarcoma.
Journal: Sarcoma
Published: December 16, 2016
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Journal: Lancet (London, England)
Published: February 15, 2016
Last Updated: 09/26/2026